These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome. Rizzo WB; Lin Z; Carney G Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053 [TBL] [Abstract][Full Text] [Related]
10. Impaired Skin Barrier Function Due to Reduced ω- Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553 [TBL] [Abstract][Full Text] [Related]
11. Compound heterozygous mutations in the Liu YD; Lin HJ; Li CY; Sun GF; Hu XB; Ma MY; Sun Y; Feng BZ; Li QB; Kong QX Int J Neurosci; 2020 Nov; 130(11):1156-1160. PubMed ID: 31944864 [No Abstract] [Full Text] [Related]
12. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome. Haug S; Braun-Falco M Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613 [TBL] [Abstract][Full Text] [Related]
13. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome. Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613 [TBL] [Abstract][Full Text] [Related]
14. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Rizzo WB; Carney G Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689 [TBL] [Abstract][Full Text] [Related]
15. A gatekeeper helix determines the substrate specificity of Sjögren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase. Keller MA; Zander U; Fuchs JE; Kreutz C; Watschinger K; Mueller T; Golderer G; Liedl KR; Ralser M; Kräutler B; Werner ER; Marquez JA Nat Commun; 2014 Jul; 5():4439. PubMed ID: 25047030 [TBL] [Abstract][Full Text] [Related]
16. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome. James PF; Zoeller RA J Biol Chem; 1997 Sep; 272(38):23532-9. PubMed ID: 9295289 [TBL] [Abstract][Full Text] [Related]
18. Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome. Lloyd MD; Boardman KD; Smith A; van den Brink DM; Wanders RJ; Threadgill MD J Enzyme Inhib Med Chem; 2007 Oct; 22(5):584-90. PubMed ID: 18035827 [TBL] [Abstract][Full Text] [Related]
19. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry. Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283 [TBL] [Abstract][Full Text] [Related]
20. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation. Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]